Androgens in Postmenopausal Women: Production, Possible Role, and Replacement Options
- 1 June 2001
- journal article
- review article
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 56 (6) , 361-376
- https://doi.org/10.1097/00006254-200106000-00022
Abstract
The physiology of normal androgen production in women has not been well understood. Aging, per se, accounts for much of the reduction in both ovarian and adrenal androgen production; and natural menopause does not result in an abrupt decline in testosterone production. Therefore, the definition of an androgen deficiency state in women, in the absence of adrenal suppression and/or bilateral oophorectomy, has been difficult. Nevertheless there are well-documented beneficial effects of androgen on many organ systems, including bone and the brain. This review focuses on the physiology of androgens in postmenopausal women and includes a discussion of the definition of an androgen deficiency state, the anticipated effects of androgen on several parameters of health, and possible ways in which androgens may be administered to women. Target Audience: Obstetricians & Gynecologists, Family Physicians Learning Objectives: After completion of this article, the reader will be able to explain the physiology of androgen production in women, outline the risks of androgen replacement, and summarize the treatment options for a women with relative androgen deficiency.Keywords
This publication has 80 references indexed in Scilit:
- Endocrine effects and pharmacokinetic characteristics of a potent new gonadotropin-releasing hormone antagonist (Ganirelix) with minimal histamine-releasing properties: studies in postmenopausal womenJournal of Clinical Endocrinology & Metabolism, 1992
- The ratio of androstenedione: 11β-hydroxyandrostenedione is an important marker of adrenal androgen excess in womenFertility and Sterility, 1992
- Concordant suppression of serum immunoreactive luteinizing hormone (LH), follicle-stimulating hormone, alpha subunit, bioactive LH, and testosterone in postmenopausal women by a potent gonadotropin releasing hormone antagonist (detirelix)Journal of Clinical Endocrinology & Metabolism, 1992
- Androstenedione is an important precursor of dihydrotestosterone in the genital skin of women and is metabolized via 5α-androstanedioneThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- Suppression of Postmenopausal Ovarian Steroidogenesis With the Luteinizing Hormone-Releasing Hormone Agonist Goserelin*Journal of Clinical Endocrinology & Metabolism, 1988
- Measurements of 3α, 17(β-androstanediol glucuronide in serum and urine and the correlation with skin 5α-reductase activityFertility and Sterility, 1986
- 1 Adrenal and gonadal androgen secretion in normal femalesClinics in Endocrinology and Metabolism, 1986
- 5α-Reductase Activity in the Genital Skin of Hirsute Women*Journal of Clinical Endocrinology & Metabolism, 1985
- Endocrine Function of the Postmenopausal Ovary: Concentration of Androgens and Estrogens in Ovarian and Peripheral Vein BloodJournal of Clinical Endocrinology & Metabolism, 1974
- Ovarian and Adrenal Contribution to Peripheral Androgens During the Menstrual CycleJournal of Clinical Endocrinology & Metabolism, 1974